Supreme Court Orders Panel to Examine Pharma Freebies for Doctors
What Happened
The Supreme Court directed the Centre to constitute a committee to examine whether stronger statutory regulations are needed to curb pharmaceutical companies from offering gifts, travel, hospitality and other incentives to doctors for prescribing their medicines. Panel should submit its recommendations to the government, which will then decide on the way forward. The issue arose from petitions seeking stricter regulation of pharmaceutical marketing practices.
Key Takeaways
The court's intervention could pave the way for tougher rules on pharma-doctor interactions, addressing concerns that freebies may influence prescription decisions and affect patient welfare.